NASDAQ: CORT · Biotechnology
Over the past week, Corcept Therapeutics (CORT) logged 11 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 11% bullish but is far apart: X runs 33% bullish while News sits at just 0%. Wall Street is more constructive, with 5 of 6 analysts rating CORT a buy.
There is little buzz around CORT this week and some agreement on direction, which is why it reads as a Sell.
Wall Street’s 83% buy share sits next to a crowd that ranges from News at 0% to X at 33%. No other tracker puts the two side by side.
Across 6 analysts the consensus is a Strong Buy: 5 buy calls against 0 sell, with an average 12-month price target of $135.25.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is mixed and the 3 sources disagree sharply, so the read is a Sell.
Analysts sit 72 points above the crowd average of 11%, the professionals are more constructive than retail. The split is inside the crowd: X reads 33% bullish while News sits at 0%, a 33-point spread that single-source trackers miss.
Over the 30-day window, Corcept Therapeutics (CORT) buzz held subdued around 26.1 while the price drifted up 26.5% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 1.3M shares. Updated Aug 15, 2026. Over the last 7 trading days, CORT gained 6.0%. Buzz activity in the recent week averaged 28.5 and was relatively stable, swinging between 21.3 and 36.2. Recent volume is running below the 30-day average, pointing to quieter participation. Daily crowd sentiment leaned bullish on 14 of the 20 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for CORT and 2000+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live CORT sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Aug 15, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Strong Buy (5 / 1 / 0) |
| Crowd bullish (7d) | 11% |
| Avg price target | $135.25 |
| Most bullish source | X, 33% |
| Most bearish source | News, 0% |
| Sentiment spread | 33 pts |
| Mentions (7d) | 11 |
| Market cap | $12.37B |
| P/E · Forward P/E | 254.4 · 58.1 |
| EPS · Beta | $0.45 · 0.5 |
| Revenue (TTM) | $830.8M · 7% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Corcept Therapeutics (CORT) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 11% bullish across 3 active sources. Those sources contribute 11 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Corcept Therapeutics (CORT) is fairly quiet with 0 mentions over the last 7 days; the 30-day context spans 1 tracked subreddits. The 7-day tone is 0% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bearish on Corcept Therapeutics (CORT), averaging 11% bullish across 3 tracked sources over the last 7 days. The two ends of the range are X at 33% bullish and News at 0%, a 33-point spread. On the professional side, 5 of 6 analysts rate CORT a buy.
Of the 6 analysts covering Corcept Therapeutics (CORT), 5 rate it a buy, 1 a hold and 0 a sell, for a strong buy consensus. The average price target is $135.25. That puts the street ahead of the crowd, which averages 11% bullish.
Corcept Therapeutics (CORT)'s cross-source average is bearish at 11% bullish. All 3 tracked sources lean bearish. X reads 33% bullish, News reads 0% bullish and reddit coverage is the most negative at 0% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for Corcept Therapeutics (CORT) at 11% bullish. All 3 tracked sources lean bearish. The most bearish reading is reddit at 0% bullish. 3-day activity momentum is falling on X, while news activity is rising. The sell signal carries 93/100 conviction.
X is the dominant discussion channel with 6 mentions (55% of total volume). News contributes 5 mentions. The cross-source average is bearish at 11% bullish, while news is the only source with rising 3-day activity. All 3 tracked sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. CORT's sell signal at 93/100 conviction reflects a bearish cross-source average at 11% bullish. All 3 tracked sources lean bearish. It is a research shortcut, not financial advice.
The CORT sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key